Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Varex Imaging Corp (VREX)

Varex Imaging Corp (VREX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,053,950
  • Shares Outstanding, K 39,400
  • Annual Sales, $ 738,300 K
  • Annual Income, $ -57,900 K
  • 60-Month Beta 0.97
  • Price/Sales 1.44
  • Price/Cash Flow 22.78
  • Price/Book 2.38
Trade VREX with:

Options Overview Details

View History
  • Implied Volatility 56.71%
  • Historical Volatility 28.50%
  • IV Percentile 26%
  • IV Rank 37.61%
  • IV High 89.95% on 11/17/20
  • IV Low 36.68% on 06/01/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.38
  • Number of Estimates 1
  • High Estimate 0.38
  • Low Estimate 0.38
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +1,050.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.70 +0.19%
on 09/22/21
29.95 -10.68%
on 09/02/21
-0.82 (-2.97%)
since 08/20/21
3-Month
24.63 +8.61%
on 07/20/21
29.95 -10.68%
on 09/02/21
-0.41 (-1.51%)
since 06/22/21
52-Week
11.33 +136.02%
on 09/25/20
29.95 -10.68%
on 09/02/21
+14.73 (+122.55%)
since 09/22/20

Most Recent Stories

More News
Boston Scientific (BSX) Strategic Buyouts Aid Amid Cost Woes

Boston Scientific (BSX) is optimistic about its recent deal to acquire Israel-based Lumenis that develops and commercializes energy-based medical solutions.

BSX : 44.31 (+2.19%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Boston Scientific's (BSX) New Buyout to Aid Clot Management

The acquisition of Devoro Medical by Boston Scientific (BSX) is expected to advance the company's core emphasis on clot management.

BSX : 44.31 (+2.19%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
NEOGEN (NEOG) to Enter Retail Parasiticide Space With New Buyout

NEOGEN's (NEOG) acquisition of CAPInnoVet expands its Animal Safety division and offers a strategic entry into the retail parasiticide market.

NEOG : 41.35 (-0.82%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Quest Diagnostics' (DGX) COVID-19 Test Demand Up in Q3 Months

The "Path Out of the Pandemic" plan of the U.S. Government, while emphasizing more on a magnified access for testing, comes as a major breakthrough for Quest Diagnostics (DGX).

DGX : 152.71 (-1.06%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Stryker's (SYK) Trauma & Extremities Arm Unveils New Product

The newly launched Citrelock Tendon Fixation Device System expands Stryker's (SYK) Foot & Ankle offerings.

SYK : 271.65 (+1.27%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Here's Why You Should Retain National Vision (EYE) For Now

Investors are optimistic about National Vision (EYE) owing to new store growth and pandemic-induced increase in demand for the company's offerings.

VREX : 26.75 (-0.56%)
EYE : 58.90 (+1.38%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Here's Why You Should Retain Boston Scientific (BSX) for Now

Investors are optimistic about Boston Scientific (BSX) given a strong second-quarter performance and strength in the Structural Heart business.

ABT : 124.65 (-0.38%)
BSX : 44.31 (+2.19%)
VREX : 26.75 (-0.56%)
BRBR : 32.22 (+2.29%)
Quest Diagnostic (DGX) Raises View on COVID-19 Testing Surge

Going by the current situation of daily increase in the coronavirus case count, Quest Diagnostics (DGX) expects COVID-19 molecular testing volumes to remain stronger through the rest of the year.

DGX : 152.71 (-1.06%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
ResMed (RMD)-Backed Landmark ALASKA Study Favors PAP Therapy

A late-breaking abstract from ResMed (RMD) supported landmark ALASKA study reported that treatment with PAP therapy improves the likelihood of longevity in sleep apnea patients

RMD : 288.48 (+0.09%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)
Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty

Smith+Nephew (SNN) introduced the RI.HIP NAVIGATION software on the CORI Surgical System and announced the commercial availability of RI.INSIGHTS at the AAOS 2021 Annual Meeting.

SNN : 36.32 (+0.58%)
VREX : 26.75 (-0.56%)
NVST : 41.80 (+1.83%)
BRBR : 32.22 (+2.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates...

See More

Key Turning Points

3rd Resistance Point 28.00
2nd Resistance Point 27.73
1st Resistance Point 27.24
Last Price 26.75
1st Support Level 26.48
2nd Support Level 26.21
3rd Support Level 25.72

See More

52-Week High 29.95
Last Price 26.75
Fibonacci 61.8% 22.84
Fibonacci 50% 20.64
Fibonacci 38.2% 18.45
52-Week Low 11.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar